Buy BPC-157 UK — HPLC-Verified Research Peptide | Regena

BPC-157 is a 15-amino-acid synthetic peptide derived from a protective protein sequence first isolated in gastric juice. The research literature has investigated its role in tendon, ligament, and gut-tissue repair pathways across in-vitro and animal models.

BPC-157 is sold as a lyophilised research peptide for in-vitro and preclinical use only. It is not a UK-licensed medicine. Regena does not sell BPC-157 for human consumption. UK research teams can order direct from our Germany, USA and China dispatch hubs with tracked, 5–14 day delivery and a research-use customs declaration.

Every BPC-157 batch is independently tested by Janoshik Analytical: reverse-phase HPLC for main-peak purity (target ≥99%), mass spectrometry for identity confirmation and Karl Fischer for residual moisture. The PDF COA matches the batch number printed on every vial cap.

Hold lyophilised BPC-157 at 2–8 °C; freeze at −20 °C for long-term storage. Reconstitute with bacteriostatic water — refrigerated in-use stability is typically 2 months. Aliquot before first freeze to avoid repeat freeze–thaw cycles.

Both are tissue-repair research peptides but act through different mechanisms. BPC-157 modulates growth-factor and angiogenic pathways; TB-500 (a fragment of thymosin beta-4) is an actin-binding peptide investigated for cell migration and wound healing. Many research teams hold both — see our full BPC-157 vs TB-500 comparison.